Sloan-Kettering was outraged by the FDA and AMA’s cover-up of B17, and for five years, studies were conducted by Sloan on the anti-cancer benefits of B17 which found that:
1. It improved the overall health of cancer patients.
2. It acted as a cancer preventative.
3. It stopped the spread of cancer in mice.
4. Laetrile inhibited tumor growth.
CONTINUE READING IN THE NEXT PAGE
